CO4940463A1 - Macrolidas cristalinas - Google Patents

Macrolidas cristalinas

Info

Publication number
CO4940463A1
CO4940463A1 CO98036359A CO98036359A CO4940463A1 CO 4940463 A1 CO4940463 A1 CO 4940463A1 CO 98036359 A CO98036359 A CO 98036359A CO 98036359 A CO98036359 A CO 98036359A CO 4940463 A1 CO4940463 A1 CO 4940463A1
Authority
CO
Colombia
Prior art keywords
crystalline
macrolides
crystalline macrolides
tautomeric
compound
Prior art date
Application number
CO98036359A
Other languages
English (en)
Inventor
Cornelia Dosenbach
Grassberger Maximilian
Otto Hartmann
Amarylla Horvath
Jean Paul Mutz
Gerard Penn
Sabine Pfeffer
Wieckhusen Dierk
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10815103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940463(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4940463A1 publication Critical patent/CO4940463A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El compuesto de la fórmula I.o una forma tautomérica o solvatada del mismo, en forma cristalina.
CO98036359A 1997-06-30 1998-06-25 Macrolidas cristalinas CO4940463A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds

Publications (1)

Publication Number Publication Date
CO4940463A1 true CO4940463A1 (es) 2000-07-24

Family

ID=10815103

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98036359A CO4940463A1 (es) 1997-06-30 1998-06-25 Macrolidas cristalinas

Country Status (32)

Country Link
US (1) US6423722B1 (es)
EP (1) EP0994880B1 (es)
JP (2) JP3880634B2 (es)
KR (1) KR100399765B1 (es)
CN (1) CN1139595C (es)
AR (1) AR017754A1 (es)
AT (1) ATE287410T1 (es)
AU (1) AU739211B2 (es)
BR (1) BR9810956A (es)
CA (1) CA2290412C (es)
CO (1) CO4940463A1 (es)
CZ (1) CZ297244B6 (es)
DE (1) DE69828692T2 (es)
DK (1) DK0994880T3 (es)
ES (1) ES2236922T3 (es)
GB (1) GB9713730D0 (es)
HK (1) HK1028597A1 (es)
HU (1) HU227755B1 (es)
ID (1) ID24897A (es)
IL (1) IL132761A0 (es)
MY (1) MY118718A (es)
NO (1) NO312765B1 (es)
NZ (1) NZ500994A (es)
PE (1) PE97699A1 (es)
PL (1) PL192761B1 (es)
PT (1) PT994880E (es)
RU (1) RU2219181C2 (es)
SK (1) SK285665B6 (es)
TR (1) TR199903189T2 (es)
TW (1) TW552264B (es)
WO (1) WO1999001458A1 (es)
ZA (1) ZA985655B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
EP2181995A3 (en) * 2003-09-03 2010-06-16 Glaxo Group Limited Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
JP2007523069A (ja) * 2004-12-01 2007-08-16 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 非吸湿性及び粉末性非晶質ピメクロリマス
EP1960406A2 (en) * 2006-11-06 2008-08-27 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
WO2008073757A1 (en) * 2006-12-07 2008-06-19 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
EP2962707B1 (en) 2009-07-17 2019-07-24 Boston Scientific Scimed, Inc. Drug delivery balloons with improved crystal size and density
EP2611476B1 (en) 2010-09-02 2016-08-10 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8669360B2 (en) * 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
SG10201707632PA (en) 2013-03-15 2017-11-29 Biosensors Int Group Ltd Purification of rapamycin derivatives
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
CA3060330A1 (en) * 2017-05-01 2018-11-08 Meda Pharma Gmbh & Co. Kg Process to convert crude ascomycin into purified pimecrolimus
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
GB2084580B (en) 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
WO1991000865A1 (en) 1989-07-10 1991-01-24 Gema S.A. A novel stable form of cephradine, process for its production and intermediates used therein
ES2077663T3 (es) * 1989-11-09 1995-12-01 Sandoz Ltd Compuestos triciclicos que contienen heteroatomos.
JPH05505798A (ja) * 1990-03-13 1993-08-26 フアイソンズ・ピーエルシー 免疫抑制マクロ環状化合物
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
ATE149483T1 (de) 1991-07-30 1997-03-15 Ajinomoto Kk Kristalle von n-(trans-4- isopropylcyclohexylcarbonyl)-d-phenylalanin und verfahren zu ihrer herstellung
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
EP0748247B1 (en) * 1994-02-22 2012-06-20 The Curators Of The University Of Missouri Macrocyclic antibiotics as separation agents
EP0848717A1 (en) * 1995-08-24 1998-06-24 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
KR20010020423A (ko) 2001-03-15
ES2236922T3 (es) 2005-07-16
SK285665B6 (sk) 2007-05-03
AU739211B2 (en) 2001-10-04
RU2219181C2 (ru) 2003-12-20
CA2290412C (en) 2009-11-10
JP3880634B2 (ja) 2007-02-14
HUP0003053A2 (hu) 2001-02-28
GB9713730D0 (en) 1997-09-03
MY118718A (en) 2005-01-31
JP4504323B2 (ja) 2010-07-14
PL192761B1 (pl) 2006-12-29
NO312765B1 (no) 2002-07-01
JP2006151999A (ja) 2006-06-15
JP2001506279A (ja) 2001-05-15
CA2290412A1 (en) 1999-01-14
DE69828692D1 (de) 2005-02-24
PT994880E (pt) 2005-06-30
EP0994880B1 (en) 2005-01-19
ATE287410T1 (de) 2005-02-15
CZ297244B6 (cs) 2006-10-11
DK0994880T3 (da) 2005-05-30
TR199903189T2 (xx) 2000-06-21
ID24897A (id) 2000-08-31
HK1028597A1 (en) 2001-02-23
SK186699A3 (en) 2000-05-16
NO995909D0 (no) 1999-12-02
PL336719A1 (en) 2000-07-03
CZ474099A3 (cs) 2000-04-12
ZA985655B (en) 1998-12-30
EP0994880A1 (en) 2000-04-26
HUP0003053A3 (en) 2003-03-28
IL132761A0 (en) 2001-03-19
KR100399765B1 (ko) 2003-09-29
NO995909L (no) 1999-12-02
NZ500994A (en) 2001-08-31
DE69828692T2 (de) 2006-01-12
PE97699A1 (es) 1999-10-29
CN1139595C (zh) 2004-02-25
AU8540998A (en) 1999-01-25
WO1999001458A1 (en) 1999-01-14
AR017754A1 (es) 2001-10-24
BR9810956A (pt) 2000-09-26
US6423722B1 (en) 2002-07-23
TW552264B (en) 2003-09-11
HU227755B1 (en) 2012-02-28
CN1261365A (zh) 2000-07-26

Similar Documents

Publication Publication Date Title
CO4940463A1 (es) Macrolidas cristalinas
NO20034660D0 (no) Spiropyrazolforbindelser
MY126559A (en) Fungicidal 2-methoxybenzophenones
DE60003709D1 (de) Substituierte azole
IS6339A (is) 2,4-Díamínópýrimidín efnasambönd nytsamleg sem ónæmisbælar
DE50009640D1 (de) Drehmaschine
ID28874A (id) Inhibitor fosfodiesterase 4 turunan ftalazina.
ID26184A (id) Hidrogenase alfa, omega-dinitril alifatik
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
IT1308756B1 (it) Punta ibrida per perforazione di roccia.
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
ITBO990171A0 (it) Macchina depallettizzatrice .
NO20023172D0 (no) 10, 11-difluormetylendioksycamptothecin-forbindelser med topoisomerase I inhibering
IT1309591B1 (it) Composizioni a rilascio controllato di betaistina.
IT1313725B1 (it) Indumento dotato di almeno un mezzo luminescente
NL1012190A1 (nl) Samenstellingen die zijn gestabiliseerd met dioxopiperazinyl-derivaten.
DK1070078T3 (da) Form VI 5,6-dichlor-2-(isopropylamino-)-1-beta-L-ribofuranosyl)-1H-benzimidazol
BR0013140B1 (pt) conjunto de maÇaneta.
IT1311662B1 (it) Struttura di calzatura.
NO20015397D0 (no) 1,5-Benzodiazepin-derivater
TR200102093T2 (tr) Organ koruyucu çözeltiler
NO20013530L (no) Organbeskyttende lösninger
ECSP993252A (es) Macrolidos
HN1999000157A (es) 1,2,3 tetrahidroquinolinas 2 - sustituidas 4 - amino sustituidas.
IT1309222B1 (it) Struttura di macchina utensile perfezionata.